These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6846131)

  • 1. Adverse effects of long-term amrinone administration in congestive heart failure.
    Dunkman WB; Wilen MM; Franciosa JA
    Am Heart J; 1983 May; 105(5):861-3. PubMed ID: 6846131
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure.
    Silverman BD; Merrill AJ; Gerber L
    Arch Intern Med; 1985 May; 145(5):825-9. PubMed ID: 3994460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with amrinone in patients with advanced congestive heart failure.
    Kinney EL; Carlin B; Ballard JO; Burks JM; Hallahan WF; Zelis R
    J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amrinone-mediated thrombocytopenia.
    Kinney EL; Ballard JO; Carlin B; Zelis R
    Scand J Haematol; 1983 Oct; 31(4):376-80. PubMed ID: 6622977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of amrinone therapy.
    Wilsmhurst PT; Webb-Peploe MM
    Br Heart J; 1983 May; 49(5):447-51. PubMed ID: 6838732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    Evans JR; Pacht K; Huss P; Unverferth DV; Bashore TM; Leier CV
    Int J Clin Pharmacol Res; 1984; 4(1):9-18. PubMed ID: 6381344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amrinone-induced hepatotoxicity.
    Gilman ME; Margolis SC
    Clin Pharm; 1984; 3(4):422-4. PubMed ID: 6467879
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.
    LeJemtel TH; Keung E; Ribner HS; Davis R; Wexler J; Blaufox JD; Sonnenblick EH
    Am J Cardiol; 1980 Jan; 45(1):123-9. PubMed ID: 7350759
    [No Abstract]   [Full Text] [Related]  

  • 10. Amrinone and exercise performance in patients with chronic heart failure.
    Weber KT; Andrews V; Janicki JS; Wilson JR; Fishman AP
    Am J Cardiol; 1981 Jul; 48(1):164-9. PubMed ID: 7246438
    [No Abstract]   [Full Text] [Related]  

  • 11. Amrinone therapy in patients with heart failure. Lack of improvement in functional capacity and left ventricular function at rest and during exercise.
    Johnston DL; Humen DP; Kostuk WJ
    Chest; 1984 Sep; 86(3):394-400. PubMed ID: 6331987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
    Massie B; Bourassa M; DiBianco R; Hess M; Konstam M; Likoff M; Packer M
    Circulation; 1985 May; 71(5):963-71. PubMed ID: 3886191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous amrinone for congestive heart failure.
    Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109
    [No Abstract]   [Full Text] [Related]  

  • 16. Amrinone-induced thrombocytopenia.
    Ansell J; Tiarks C; McCue J; Parrilla N; Benotti JR
    Arch Intern Med; 1984 May; 144(5):949-52. PubMed ID: 6712412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amrinone in acute and long-term therapy].
    Klepzig M; Kleinhans E; Büll U; Strauer BE
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of amrinone on platelet count, survival and function in patients with congestive cardiac failure.
    Wilmshurst PT; Al-Hasani SF; Semple MJ; Hamblin AS; Kioy PG; Lucas GF; Savidge GF; Webb-Peploe MM
    Br J Clin Pharmacol; 1984 Mar; 17(3):317-24. PubMed ID: 6712864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral amrinone in refractory congestive heart failure.
    Wynne J; Malacoff RF; Benotti JR; Curfman GD; Grossman W; Holman BL; Smith TW; Braunwald E
    Am J Cardiol; 1980 Jun; 45(6):1245-9. PubMed ID: 7377123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amrinone therapy in congestive cardiomyopathy.
    Reader C; Peyregne EA; Suárez LD
    Am Heart J; 1983 Jun; 105(6):1045. PubMed ID: 6858829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.